• News
  • Finance

Novartis Buys Glaxo Cancer Unit, Sells Animal Drugs to Lilly (4)

April 22 (Bloomberg) -- Novartis AG will focus more on cancer, GlaxoSmithKline Plc on vaccines and Eli Lilly & Co. on animal health as the drugmakers announced a series of deals for a total of as much as $28.5 billion today.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!